Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: GOOG NFLX BIIB AMZN IBB TSLA ILMN ALXN WYNN AMGN GMCR SLXP COST FFIV SSYS VRTX SBAC GILD Z
Nyse: ACT V LNKD MCK IVV LMT AGN GS PXD SPG FDX IBM MMM TWC CMI GD HUM NOC APD BDX
New Highs: BLK IBB V SHW MCK IVV ILMN ALXN LMT GS PSA SPG ORLY WHR FDX BCR AMGN MMM GMCR FLT

The Hot Industries

Biotechnology 3
Medical Instruments & Supplies 1
Appliances 1

The Hot Sectors

Financial 5
Healthcare 4
Services 4

ILMN Stock Chart


ILMN
Analyze

Sector:

Healthcare
Daily

Industry:

Biotechnology
Weekly

Employees:

3,000
Monthly

Website:

http://www.illumina.com

ILMN Illumina Inc.

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company’s products include sequencing platforms that are based on its SBS technology are designed to meet the various demands of a range of sequencing applications; and array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of array-based genetic analysis products. It also offers various sample preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping and whole genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

favicon

Incyte (INCY) Looks Good: Stock Moves 10.9% Higher

31 Oct 2014, 6:13 amIncyte (INCY) was a big mover last session, with shares rising nearly 11% on the day.
favicon

Bristol-Myers Squibb (BMY) Jumps: Stock Moves Up 8.9%

31 Oct 2014, 1:11 amBristol-Myers Squibb Company (BMY) was a big mover last session, as its shares rose nearly 9% on the day.
favicon

Novo Nordisk A/S (NVO) Shows Strength: Stock Up 6.2%

31 Oct 2014, 1:07 amNovo Nordisk A/S (NVO) was a big mover last session, as its shares rose over 6% on the day.
favicon

Oncolytics Biotech (ONCY) Looks Good: Stock Soars 26%

30 Oct 2014, 6:14 amOncolytics Biotech (ONCY) was a big mover last session, with shares surging almost 26% on the day.
favicon

Can Illumina (ILMN) Stock Continue to Grow Earnings? - Tale of the Tape

28 Oct 2014, 9:17 amCan Illumina (ILMN) Stock Continue to Grow Earnings? - Tale of the Tape
favicon

Can Illumina (ILMN) Stock Continue to Grow Earnings?

28 Oct 2014, 4:44 amIllumina is well-positioned for future earnings growth and could be a strong growth stock contender
favicon

Surging Earnings Estimates Signal Good News for Illumina Inc. (ILMN)

27 Oct 2014, 4:44 amIllumina Inc. (ILMN) sees solid earnings estimate revisions for the current quarter and current year, and the stock is showing decent short-term momentum as well, rising over 15% in the past month.
favicon

Illumina (ILMN) Looks Strong: Stock Gains 9.2%

22 Oct 2014, 4:43 amIllumina (ILMN) was a big mover last session, as the company saw its shares jump over 9% on the day
favicon

Why Illumina (ILMN) Stock Is Soaring Today

21 Oct 2014, 8:14 amNEW YORK (TheStreet) -- Shares of Illumina Inc are soaring, up 8.83% to $179 in early market trading Tuesday, after the company was upgraded to "buy" from "neutral" with a higher price target of $192 from $165 at Janney Capital. Anlaysts at the firm cited the company's third quarter earnings beat over analyst estimates for the raise in rating. Janney Capital also said its checks indicated that ...
favicon

Why Illumina (ILMN) Stock Is Gaining in After-Hours Trading Today

20 Oct 2014, 3:29 pmNEW YORK (TheStreet) -- Illumina shares are up 9.75% to $180.50 in after-hours trading on Monday after the company reported third quarter earnings results ahead of analysts expectations. The San Diego-based life sciences diagnostic company reported third quarter earnings of 77 cents per diluted share, well ahead of the 56 cents per diluted share analysts were expecting for the period. Must Read ...